Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Luminex Corp (NASDAQ:LMNX)

20.54
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
17.68
Today|||52-Week Range
22.42
+1.53%
Year-to-Date
Genomic Health-Janssen Pharma Tie Up, GPS Test in Focus
Dec 08 / Zacks.com - Paid Partner Content
ResMed (RMD) Rides on Innovation Amid Reimbursement Woes
Dec 01 / Zacks.com - Paid Partner Content
Veeva Systems (VEEV) Beats on Earnings in Q3, Updates View
Dec 06 / Zacks.com - Paid Partner Content
Bio-Rad (BIO) at a 52-Week High: What's Driving the Stock?
Dec 01 / Zacks.com - Paid Partner Content
Ecolab Focuses on Pest Elimination, Acquires 3 Companies
Dec 05 / Zacks.com - Paid Partner Content
BioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring
Dec 01 / Zacks.com - Paid Partner Content
Boston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay
Dec 01 / Zacks.com - Paid Partner Content
Here's Why You Should Add Chemed (CHE) to Your Portfolio Now
Dec 01 / Zacks.com - Paid Partner Content
BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo
Dec 01 / Zacks.com - Paid Partner Content
Flexion's (FLXN) Zilretta Therapy to Fast Capture OA Market
Nov 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close20.54
Today’s open20.55
Day’s range20.44 - 20.65
Volume105,399
Average volume (3 months)170,410
Market cap$904.9M
Dividend yield1.17%
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)-62.79%
Earnings growth (this year)+6.73%
Earnings growth (next 5 years)-4.39%
Revenue growth (last year)+13.85%
P/E ratio31.1
Price/Sales3.22
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc0.000.00%
ANIKAnika Therapeutics I...0.000.00%
ATRCAtriCure Inc0.000.00%
LMATLeMaitre Vascular In...0.000.00%
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateFebruary 5, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$270.6M
Annual profit (last year)$13.8M
Net profit margin5.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nachum Shamir
Chief Financial Officer, Treasurer &
SVP-Finance
Harriss T. Currie
Corporate headquarters
Austin, Texas

Forecasts